This program is free to all healthcare providers regardless of membership. 

PRE-REQUISITE: You must complete De-Stress Pain Management: Rethinking Opioid and Non-Opioid Therapies before you can receive credit this case forum.

Course Expires: October 31, 2024


OVERVIEW

As a continuation to the free interactive series, De-Stress Pain Management: Rethinking Opioid and Non-Opioid Therapies, ACOI and ACOFP hosted a live case forum on pain management on June 12, 2024. This activity is a recording of that forum, which was facilitated by Robert Agnello, DO, FACOFP, and Rachel Sanchez, DO. Within each case forum, the facilitators discuss actual patient cases and approaches to overcoming opioid misuse and opioid use disorder.


OBJECTIVES

  • State the role of both prescription and illicit opioids within osteopathic care
  • Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain guided by osteopathic philosophy
  • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD)
  • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment
  • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management
  • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services


ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians.

ACOFP designates this enduring activity series for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.


CREDIT DESIGNATION STATEMENT

ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

ACOFP designates this enduring activity series for a maximum of 1.5 AOA Category 1-A Credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.


DEA TRAINING FULFILLMENT

As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.


SUPPORT ACKNOWLEDGEMENT

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Category 1A